Meghan Jeffres
banner
pharmermeg.bsky.social
Meghan Jeffres
@pharmermeg.bsky.social
ID Pharm, antibiotic allergies, UTIs, MedEd fun & games
Podcaster: Medical Rewrites
https://tinyurl.com/MedRewrites (Apple)
https://tinyurl.com/MedRewrite (Spotify)
Reposted by Meghan Jeffres
This is super exciting. JAK1 inhibitor turns out to be a very effective treatment for TEN/SJS

www.nature.com/articles/s41...
www.nature.com
November 24, 2024 at 3:20 AM
Reposted by Meghan Jeffres
Hi #IDSky! I’m putting together my usual top 10 ID papers of this year list again (this time will post here not in the other world).

Please tell me your candidate papers - practice changing paradigm shifting or dogma challenging!
November 21, 2024 at 8:45 PM
Reposted by Meghan Jeffres
New paper from my colleagues at UCLH

Nearly 70% (!!!) resistance to Cefiderocol in NDM positive bacteria.

Cefiderocol...we hardly knew ye...

Perfect timing for World Antimicrobial Awareness Week #waaw24 #IDSky

academic.oup.com/jac/advance-...
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
AbstractBackground. Carbapenemase-producing Enterobacterales (CPE) pose difficult therapeutic challenges. We aimed to characterize antimicrobial resistance
academic.oup.com
November 18, 2024 at 10:34 AM
Reposted by Meghan Jeffres
Incredible graphic - the myriad of ways that bacteria defend themselves against antibiotics.

14 resistance mechanisms, summarised by Idan Yelin & Roy Kishony in Cell

www.sciencedirect.com/science/arti...
November 13, 2024 at 12:46 PM
Reposted by Meghan Jeffres
Morning #IDSky what is your preferred rounding structure for teaching services? Would love to know why in comments 👇

1️⃣ <a href="https://poll.blue/p/b0UxKV/1" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">AM team rounds
2️⃣ <a href="https://poll.blue/p/b0UxKV/2" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">PM team rounds
3️⃣ <a href="https://poll.blue/p/b0UxKV/3" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">BID team rounds
4️⃣ <a href="https://poll.blue/p/b0UxKV/4" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky">Keep it flexible

📊 Show results
November 13, 2024 at 4:01 PM
ID Connections #2
Same game as the NYT Connections but with ID content and unlimited guesses.
connections.swellgarfo.com/game/-OBYIEo...
November 13, 2024 at 2:20 AM
Reposted by Meghan Jeffres
Interesting! SubQ meropenem.

“Subcutaneous meropenem appears to be well tolerated and has a favourable pharmacokinetic profile. Either 1.5 g twice daily or 3 g as a 24 h subcutaneous infusion could be considered for future evaluation.”

academic.oup.com/jac/advance-...
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administration
AbstractBackground. Subcutaneous delivery of antibiotics is a practical alternative to IV administration. Meropenem is commonly used to treat infections ca
academic.oup.com
November 12, 2024 at 4:01 AM
Reposted by Meghan Jeffres
Can we treat patients with low-risk BSI discharged from the ED with a fully-oral course of antibiotics?

[Spoiler: Yes!]

🆓🔓Our recent article on #OralIsTheNewIV! 👉🏻 journals.asm.org/doi/10.1128/...

Food for thought for #AMSsky #IDSky
Safety of early oral ambulatory treatment of adult patients with bloodstream infections discharged from the emergency department | Antimicrobial Agents and Chemotherapy
Randomized trials have unanimously shown the benefits of oral antibiotic treatments for stable patients with bacteremia (1). However, transition to oral therapy has been usually performed after several days of intravenous treatment—frequently up to 7 days (2)—highlighting the need for evidence of the safety of earlier oral treatments (3).
journals.asm.org
November 12, 2024 at 7:30 PM
Reposted by Meghan Jeffres
My Top 5 Antibiotic Allergy Papers - #5
▶️Gadde et al. JAMA 1993; 270 (20)
▶️ A paper before its time. Skin testing for #penicillinallergy in patients with ID indication!
▶️ 7.1% + ; PPL & MDM utilisation; safety (1/128+ required adrenaline); Allergy LOSS WITH TIME.
jamanetwork.com/journals/jam...
Clinical Experience With Penicillin Skin Testing in a Large Inner-City STD Clinic
Objective.  —To establish (1) the prevalence of positive penicillin skin tests among outpatients with well-defined but variable history of penicillin allergy and (2) the reproducibility, safety, a...
jamanetwork.com
November 12, 2024 at 3:52 AM
Reposted by Meghan Jeffres
To get hopefully some #peniicillinallergy #drugallergy folk over to 🦋 from X I am going to list my top 5 #antibioticallergy papers of all time - starting tomorrow! Stay tuned 👀
November 11, 2024 at 10:05 AM
Very happy to report that @sidpharm.bsky.social and @mad-id.bsky.social is here. Waiting on SHEA...
#MedSky contact your professional societies and ask them to create Bluesky accounts.
November 11, 2024 at 6:14 PM
Reposted by Meghan Jeffres
I'm advertising a PhD studentship (open to international students) working on long read pangenome / assembly algorithms in bacteria. Would suit someone with maths/compsci/coding background. Aptitude + interest more important than experience.
Details here:
www.findaphd.com/phds/project...
New graph algorithms for analysis of the genomes and pangenomes of bacteria and their mobile elements. at University of Bath on FindAPhD.com
PhD Project - New graph algorithms for analysis of the genomes and pangenomes of bacteria and their mobile elements. at University of Bath, listed on FindAPhD.com
www.findaphd.com
November 11, 2024 at 2:23 PM
Reposted by Meghan Jeffres
Hello #IDSky #MedSky #PharmSky!

We are MAD-ID, striving to educate 🎓 and promote 🏆 infectious diseases and antimicrobial stewardship clinicians and researchers!

Looking forward to the bright future of our ID community on this platform 🦋
November 11, 2024 at 5:15 PM
Reposted by Meghan Jeffres
Here’s pack 2! Still in progress - will update more tomorrow.

It’s been a fun day. Love seeing our community rebuild here! Goodnight Bluesky. 🦋💤
November 11, 2024 at 6:53 AM
Reposted by Meghan Jeffres
Along the lines of what others have started, here's a #SkyRx starter pack - if I'm missing you let me know!

go.bsky.app/DTkEEWG
November 8, 2024 at 2:40 PM
Reposted by Meghan Jeffres
IDSky continues to grow rapidly

We are now >300 users, which means we are on a third Starter Pack

IDSky Starter Pack 1 go.bsky.app/LnAQjdq
IDSky Starter Pack 2 go.bsky.app/JNfSvQT
ID Starter Pack 3 go.bsky.app/FeogT7o

Check back on the most recent one often as it is updated frequently
November 10, 2024 at 2:33 AM
Reposted by Meghan Jeffres
Hi friends on #IDSky. Hoping we re-create what we once had on twixter.

So here's another old favorite, guaranteed to get your Sunday off to a happy start.

(Grrrr ... still mad about this one.)
blogs.jwatch.org/hiv-id-obser...
How to Induce Rage in a Doctor
If you’re wondering how to make a doctor angry — really, really angry — read on. Because asking us to justify treatment decisions to insurance companies and their pharmacy benefit managers must rank r...
blogs.jwatch.org
November 10, 2024 at 11:32 AM
Reposted by Meghan Jeffres
PSA: If you’re ever reversing anticoagulation & someone asks if the patient has had a vasectomy, they’re not being a weirdo.

Protamine is made from salmon sperm & post vasectomy patients may have anti sperm antibodies that cross react causing life threatening anaphylaxis!
November 10, 2024 at 12:36 AM
Reposted by Meghan Jeffres
🔍👁️🍄 “Based on available evidence, and high risk of morbidity of eye involvement, continued ophthalmological screens seem prudent, but a definitive consensus was found to be challenging given a lack of outcome data...”

academic.oup.com/ofid/advance... #IDbluesky
November 9, 2024 at 7:27 PM
Fun ID Pharm Q today
Pt on mero 2q8 for ESBL infx and has adenovirus viremia.

Starting cidofovor + probenecid = mero dose adjustment

1989 study to the rescue! Mero AUC ⬆️ 55%. T1/2 ⬆️ from 0.9 hr to 1.3 hr.

➡️ 2 Q12 x 48 hrs based on probenecid t1/2 of 5-15 hrs

pubmed.ncbi.nlm.nih.gov/2808215/
The pharmacokinetics of meropenem in volunteers - PubMed
Two human volunteer studies were performed with meropenem: a dose proportionality study of 0.25, 0.5 and 1.0 g and a probenecid interaction study. Six volunteers took part in each study. Meropenem was...
pubmed.ncbi.nlm.nih.gov
November 9, 2024 at 3:10 AM
Looking to build/join the ID peeps

I make ID themed games. Obsessed with beta-lactam side chains. New fan of topical estrogen for rUTIs.

connections.swellgarfo.com/game/-NuSggy...
November 8, 2024 at 1:59 AM